Companion Diagnostics: Future of Personalized Medicine
Companion diagnostics (CDx) refer to a type of in vitro diagnostic tests intended to assist physicians or medical professionals to make effective treatment decisions based on the patient response to a targeted therapy. These tests map a patient's likely response to the ongoing therapy thereby, enabling the optimization of appropriate dosing concentrations and possible course of treatment. With the increasing popularity of personalized medicine, pharmaceutical companies are shifting their focus towards the development of individualized treatment products rather than conventional...
View full press release